Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for Sickle Cell Disease

NCT03282656 is registered in ClinicalTrials.gov with David Williams as lead sponsor.

NCT NCT03282656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03282656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for Sickle Cell Disease
Lead sponsor
David Williams
Phase
Phase 1
Overall status
Active, not recruiting
Start date
February 13, 2018
Completion date
November 13, 2026
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease